Track topics on Twitter Track topics that are important to you
SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery of innovative medicines over a broad range of therapy areas.In the discovery phase SCYNEXIS offers its services primarily in the form of integrated research teams consisting of medicinal chemists, computational chemists, analytical chemists and bioanalytical scientists to work on a collaborative basis with our customers on projects from hit to candidate selection. SCYNEXIS project leaders of these multi-disciplinary teams are knowledgeable scientists with years of industry experience. They coordinate and communicate key activities and drive resources to achieve success. SCYNEXIS research teams use powerful, proprietary technologies such as the HEOS® Software Suite, MEDCHEM-FACTORY™ and KIT™ Kinase Inhibitor Technology to deliver maximum results to our customers.
Post Office Box 12878
Research Triangle Park
United States of America
Phone: (919) 544-8600
Fax: (919) 544-8697
SCYNEXIS and Impax Laboratories are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, v...
SCYNEXIS and Impax Laboratories are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, va...
"Scott brings invaluable legal and strategic expertise to SCYNEXIS as we continue to advance our lead asset, SCY-078, through clinical development," said Marco Taglietti, Read more...
Additional SCY-078 Posters to be Presented at 8th Trends in Medical Mycology Pre-clinical data further highlight SCY-078’s broad spectrum of activity and differentiated attributes JERSEY CITY,...
JERSEY CITY, N.J., Oct. 05, 2017 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-thr...
SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences indu...
We have published hundreds of SCYNEXIS, Inc. news stories on BioPortfolio along with dozens of SCYNEXIS, Inc. Clinical Trials and PubMed Articles about SCYNEXIS, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SCYNEXIS, Inc. Companies in our database. You can also find out about relevant SCYNEXIS, Inc. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...